Swisse acquired by Biostime
Biostime acquired Swisse, an Australian vitamins & supplements brand.
Transaction summary
Value and multiples
100% enterprise value
AUD 1.7B
100% enterprise value | AUD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
Approx. $1.2B USD using FX date 2015-09-17 at 0.7170 AUD/USD.
EV / revenue
3.65x
Period: LTM August 2015
Basis: Derived from source data
EV / EBITDA
10.2x
EBITDA basis not stated
Basis: Derived from source data
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 1.7B
Google News headlines from SMH.com.au and The Age dated 2015-09-17 state Swisse was bought by Biostime for $1.67 billion; fetched evidence does not specify currency or EV/equity basis.
Basis
- Biostime’s Swisse partnership presentation reports AUD 1,670m enterprise value for the whole company and an 83% acquisition. The old USD label and 2.5% stake were incorrect. No further division by 83%.
Other reviewed estimates
Earlier estimates and their sources.
Source summary
Swisse bought by Hong Kong company Biostime for $1.67 billion - SMH.com.au
Confirmed100% EV basis review
ConfirmedBiostime’s Swisse partnership presentation reports AUD 1,670m enterprise value for the whole company and an 83% acquisition. The old USD label and 2.5% stake were incorrect. No further division by 83%.
Open sourceThorne HealthTech Schedule 14D-9/A
EstimatedPrecedent transaction row lists implied TEV of $1,199m and TEV/LTM Adjusted EBITDA of 10.2x.
Open sourceContinue your research
Related transaction comps
Twinlab acquired by cbdMD
2026-09-02 · Confirmed
View transaction → SupplementsCare/of acquired by Bayer
2020-08-31 · Confirmed
View transaction → SupplementsJamieson Wellness acquired by Kirin Holdings Company
2026-08-06 · Confirmed
View transaction → SupplementsThorne acquired by Procter & Gamble
2026-08-04 · Estimated
View transaction →